Menopausal hot flushes and vascular health

References

• Deecher DC, Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health. 2007;10:247–57.
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: A systematic review. Climacteric. 2007;10:197–214.
   PubMed Web of Science ®Google Scholar
• Sturdee DW. The menopausal hot flush—anything new? Maturitas. 2008;60:42–9.
   PubMed Web of Science ®Google Scholar
• Stefanick ML. Estrogens and progestins: Background and history, trends in use, and guidelines and regimens approved by the US food and drug administration. Am J Med. 2005; 118 Suppl 12B:64–73.
   Google Scholar
• Taskinen MR. Oestrogen replacement therapy and coronary heart disease. Ann Med. 1998;30:443–51.
   PubMed Web of Science ®Google Scholar
• Nair GV, Klein KP, Herrington DM. Assessing the role of oestrogen in the prevention of cardiovascular disease. Ann Med. 2001;33:305–12.
   PubMed Web of Science ®Google Scholar
• Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, . Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 1992;117: 1016–37.
   PubMed Web of Science ®Google Scholar
• Barrett-Connor E. The menopause, hormone replacement, and cardiovascular disease: The epidemiologic evidence. Maturitas. 1996;23:227–34.
   PubMed Web of Science ®Google Scholar
• Hu FB, Grodstein F. Postmenopausal hormone therapy and the risk of cardiovascular disease: The epidemiologic evidence. Am J Cardiol. 2002;90:26F–9F.
   Web of Science ®Google Scholar
• Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, . Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin replacement study (HERS) research group. JAMA. 1998;280: 605–13.
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, . Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin replacement study follow-up (HERS II). JAMA. 2002;288: 49–57.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, . Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial. JAMA. 2002;288:321–33.
   PubMed Web of Science ®Google Scholar
• Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, . Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med. 2003;349:523–34.
   PubMed Web of Science ®Google Scholar
• Herrington DM, Klein KP. Randomized clinical trials of hormone replacement therapy for treatment or prevention of cardiovascular disease: A review of the findings. Atherosclerosis. 2003;166:203–12.
   PubMed Web of Science ®Google Scholar
• Ylikorkala O. HRT as secondary prevention of cardiovascular disease. Maturitas. 2004;47:315–8.
   PubMed Web of Science ®Google Scholar
• Grodstein F, Clarkson TB, Manson JE. Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med. 2003;348:645–50.
   PubMed Web of Science ®Google Scholar
• Mikkola TS, Clarkson TB, Notelovitz M. Postmenopausal hormone therapy before and after the women's health initiative study: What consequences? Ann Med. 2004;36:402–13.
   PubMed Web of Science ®Google Scholar
• Mikkola TS, Clarkson TB. Estrogen replacement therapy, atherosclerosis, and vascular function. Cardiovasc Res. 2002; 53:605–19.
   PubMed Web of Science ®Google Scholar
• Mikkola TS, Ylikorkala O. Hormone therapy and cardiovascular disease—still much to be learnt. Gynecol Endocrinol. 2005;20:116–20.
   PubMed Web of Science ®Google Scholar
• Mikkola TS, Clarkson TB. Coronary heart disease and postmenopausal hormone therapy: Conundrum explained by timing? J Womens Health (Larchmt). 2006;15:51–3.
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: The role of time since menopause and age at hormone initiation. J Womens Health (Larchmt). 2006;15:35–44.
   PubMed Web of Science ®Google Scholar
• Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, . Conjugated equine estrogens and coronary heart disease: The women's health initiative. Arch Intern Med. 2006;166:357–65.
   PubMed Web of Science ®Google Scholar
• Ouyang P, Michos ED, Karas RH. Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol. 2006;47: 1741–53.
   PubMed Web of Science ®Google Scholar
• Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, . Estrogen therapy and coronary-artery calcification. N Engl J Med. 2007;356:2591–602.
   PubMed Web of Science ®Google Scholar
• Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, . Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465–77.
   PubMed Web of Science ®Google Scholar
• Hernan MA, Alonso A, Logan R, Grodstein F, Michels KB, Willett WC, . Observational studies analyzed like randomized experiments: An application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008;19:766–79.
   PubMed Web of Science ®Google Scholar
• Sourander L, Rajala T, Raiha I, Makinen J, Erkkola R, Helenius H. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet. 1998;352:1965–9.
   PubMed Web of Science ®Google Scholar
• van der Schouw YT, Grobbee DE. Menopausal complaints, oestrogens, and heart disease risk: An explanation for discrepant findings on the benefits of post-menopausal hormone therapy. Eur Heart J. 2005;26:1358–61.
   PubMed Web of Science ®Google Scholar
• Mendelsohn ME, Karas RH. HRT and the young at heart. N Engl J Med. 2007;356:2639–41.
   PubMed Web of Science ®Google Scholar
• Allison MA, Manson JE. The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk. Menopause. 2009;16:619–20.
   PubMed Web of Science ®Google Scholar
• Andrikoula M, Hardiman P, Prelevic G. Menopausal hot flush: Is it only a nuisance or also a marker of cardiovascular risk? Gynecol Endocrinol. 2009;27:450–4.
   Google Scholar
• Pinkerton JV, Stovall DW. Is there an association between vasomotor symptoms and both low bone density and cardiovascular risk? Menopause. 2009;16:219–23.
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Pepe A. Vasomotor symptoms and cardiovascular risk. Climacteric. 2009;12 Suppl 1:32–5.
   PubMed Web of Science ®Google Scholar
• The Women's Health Initiative Study Group. Design of the Women's health initiative clinical trial and observational study. Control Clin Trials. 1998;19:61–109.
   PubMedGoogle Scholar
• Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med. 2005;23:117–25.
   PubMed Web of Science ®Google Scholar
• Rossmanith WG, Ruebberdt W. What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause. Gynecol Endocrinol. 2009;25:303–14.
   PubMed Web of Science ®Google Scholar
• Overlie I, Moen MH, Holte A, Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas. 2002;41:69–77.
   PubMed Web of Science ®Google Scholar
• Randolph JF Jr, Sowers M, Bondarenko I, Gold EB, Greendale GA, Bromberger JT, . The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab. 2005;90:6106–12.
   PubMed Web of Science ®Google Scholar
• Barton D, Loprinzi C, Wahner-Roedler D. Hot flashes: Aetiology and management. Drugs Aging. 2001;18:597–606.
   PubMed Web of Science ®Google Scholar
• Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot flashes. Mayo Clin Proc. 2002;77:1207–18.
   PubMed Web of Science ®Google Scholar
• Whiteman MK, Staropoli CA, Benedict JC, Borgeest C, Flaws JA. Risk factors for hot flashes in midlife women. J Womens Health (Larchmt). 2003;12:459–72.
   PubMed Web of Science ®Google Scholar
• Rapkin AJ. Vasomotor symptoms in menopause: Physiologic condition and central nervous system approaches to treatment. Am J Obstet Gynecol. 2007;196:97–106.
   PubMed Web of Science ®Google Scholar
• Pontiroli AE, Pizzocri P, Paroni R, Folli F. Sympathetic overactivity, endothelial dysfunction, inflammation, and metabolic abnormalities cluster in grade III (world health organization) obesity: Reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding. Diabetes Care. 2006;29:2735–8.
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Angeli F, Reboldi G. Optimizing the definition of dippers and nondippers: Is a 70–86% full glass empty? J Hypertens. 2008;26:630–2.
   PubMedGoogle Scholar
• Vongpatanasin W. Autonomic regulation of blood pressure in menopause. Semin Reprod Med. 2009;27:338–45.
   PubMed Web of Science ®Google Scholar
• Grassi G, Arenare F, Quarti-Trevano F, Seravalle G, Mancia G. Heart rate, sympathetic cardiovascular influences, and the metabolic syndrome. Prog Cardiovasc Dis. 2009;52:31–7.
   PubMed Web of Science ®Google Scholar
• Santoro N. Symptoms of menopause: Hot flushes. Clin Obstet Gynecol. 2008;51:539–48.
   PubMed Web of Science ®Google Scholar
• Rödström K, Bengtsson C, Lissner L, Milsom I, Sundh V, Björkelund C. A longitudinal study of the treatment of hot flushes: The population study of women in Gothenburg during a quarter of a century. Menopause. 2002;9:156–61.
   PubMed Web of Science ®Google Scholar
• Gold EB, Colvin A, Avis N, Bromberger J, Greendale GA, Powell L, . Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of women's health across the nation. Am J Public Health. 2006;96:1226–35.
   PubMed Web of Science ®Google Scholar
• Williams RE, Kalilani L, DiBenedetti DB, Zhou X, Granger AL, Fehnel SE, . Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric. 2008;11:32–43.
   PubMed Web of Science ®Google Scholar
• Col NF, Guthrie JR, Politi M, Dennerstein L. Duration of vasomotor symptoms in middle-aged women: A longitudinal study. Menopause. 2009;16:453–7.
   PubMed Web of Science ®Google Scholar
• Sievert LL. Variation in sweating patterns: Implications for studies of hot flashes through skin conductance. Menopause. 2007;14:742–51.
   PubMedGoogle Scholar
• Kronenberg F. Menopausal hot flashes: A review of physiology and biosociocultural perspective on methods of assessment. J Nutr. 2010;140:1380S–5S.
   PubMed Web of Science ®Google Scholar
• Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001;19:4280–90.
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Barton DL. On hot flash mechanism, measurement, and treatment. Menopause. 2009;16:621–3.
   PubMed Web of Science ®Google Scholar
• Leal M, Diaz J, Serrano E, Abellan J, Carbonell LF. Hormone replacement therapy for oxidative stress in postmenopausal women with hot flushes. Obstet Gynecol. 2000; 95:804–9.
   PubMed Web of Science ®Google Scholar
• Beljic T, Babic D, Marinkovic J, Prelevic GM. Effect of estrogen replacement therapy on cardiac function in postmenopausal women with and without flushes. Gynecol Endocrinol. 1999;13:104–12.
   PubMed Web of Science ®Google Scholar
• Brown DE, Sievert LL, Aki SL, Mills PS, Etrata MB, Paopao RN, . Effects of age, ethnicity and menopause on ambulatory blood pressure: Japanese-American and Caucasian school teachers in Hawaii. Am J Hum Biol. 2001;13:486–93.
   PubMed Web of Science ®Google Scholar
• James GD, Sievert LL, Flanagan E. Ambulatory blood pressure and heart rate in relation to hot flash experience among women of menopausal age. Ann Hum Biol. 2004; 31:49–58.
   PubMed Web of Science ®Google Scholar
• Gerber LM, Sievert LL, Warren K, Pickering TG, Schwartz JE. Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause. 2007;14:308–15.
   PubMed Web of Science ®Google Scholar
• Freedman RR, Dinsay R. Clonidine raises the sweating threshold in symptomatic but not in asymptomatic postmenopausal women. Fertil Steril. 2000;74:20–3.
   PubMed Web of Science ®Google Scholar
• Low DA, Davis SL, Keller DM, Shibasaki M, Crandall CG. Cutaneous and hemodynamic responses during hot flashes in symptomatic postmenopausal women. Menopause. 2008; 15:290–5.
   PubMedGoogle Scholar
• Nelesen R, Krohn P, Dimsdale JE. Hot-flash hypotension. N Engl J Med. 2004;351:1577–9.
   PubMedGoogle Scholar
• Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: Findings from the study of women's health across the nation heart study. Circulation. 2008;118:1234–40.
   PubMed Web of Science ®Google Scholar
• Bechlioulis A, Naka KK, Papanikolaou O, Kontostolis E, Kalantaridou SN, Michalis LK. Menopause and hormone therapy: From vascular endothelial function to cardiovascular disease. Hellenic J Cardiol. 2009;50:303–15.
   PubMedGoogle Scholar
• Gast GC, Grobbee DE, Pop VJ, Keyzer JJ, Wijnands-van Gent CJ, Samsioe GN, . Menopausal complaints are associated with cardiovascular risk factors. Hypertension. 2008;51:1492–8.
   PubMed Web of Science ®Google Scholar
• Gast GC, Samsioe GN, Grobbee DE, Nilsson PM, van der Schouw YT. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women. Maturitas. 2010; 66:285–90.
   PubMed Web of Science ®Google Scholar
• Gallicchio L, Miller SR, Zacur H, Flaws JA. Hot flashes and blood pressure in midlife women. Maturitas. 2010;65: 69–74.
   PubMed Web of Science ®Google Scholar
• Huang AJ, Grady D, Jacoby VL, Blackwell TL, Bauer DC, Sawaya GF. Persistent hot flushes in older postmenopausal women. Arch Intern Med. 2008;168:840–6.
   PubMed Web of Science ®Google Scholar
• Tuomikoski P, Ebert P, Groop PH, Haapalahti P, Hautamäki H, Rönnback M, . Evidence for a role of hot flushes in vascular function in recently postmenopausal women. Obstet Gynecol. 2009;113:902–8.
   PubMed Web of Science ®Google Scholar
• Tuomikoski P, Haapalahti P, Ylikorkala O, Mikkola TS. Vasomotor hot flushes and 24-hour ambulatory blood pressure in recently post-menopausal women. Ann Med. 2010; 42:216–22.
   PubMed Web of Science ®Google Scholar
• Tuomikoski P, Mikkola TS, Hämäläinen E, Tikkanen MJ, Turpeinen U, Ylikorkala O. Biochemical markers for cardiovascular disease in recently postmenopausal women with and without hot flashes. Menopause. 2009;17:145–51.
   Web of Science ®Google Scholar
• Tuomikoski P, Ebert P, Groop PH, Haapalahti P, Hautamäki H, Rönnback M, . Effect of hot flushes on vascular function; A randomized controlled trial. Obstet Gynecol. 2009; 114:777–85.
   PubMed Web of Science ®Google Scholar
• Tuomikoski P, Haapalahti P, Sarna S, Ylikorkala O, Mikkola TS. Vasomotor hot flushes and 24-hour ambulatory blood pressure in normotensive women: A placebo-controlled trial on post-menopausal hormone therapy. Ann Med. 2010;42: 334–43.
   PubMed Web of Science ®Google Scholar
• Tuomikoski P, Mikkola TS, Tikkanen MJ, Ylikorkala O. Hot flushes and biochemical markers for cardiovascular disease: A randomized trial on hormone therapy. Climacteric. 2010; 13:457–66.
   PubMed Web of Science ®Google Scholar
• Davies JI, Struthers AD. Pulse wave analysis and pulse wave velocity: A critical review of their strengths and weaknesses. J Hypertens. 2003;21:463–72.
   PubMedGoogle Scholar
• Hamilton PK, Lockhart CJ, Quinn CE, McVeigh GE. Arterial stiffness: Clinical relevance, measurement and treatment. Clin Sci (Lond). 2007;113:157–70.
   PubMed Web of Science ®Google Scholar
• Zoungas S, Asmar RP. Arterial stiffness and cardiovascular outcome. Clin Exp Pharmacol Physiol. 2007;34:647–51.
   PubMed Web of Science ®Google Scholar
• Safar ME. Pulse pressure, arterial stiffness and wave reflections (augmentation index) as cardiovascular risk factors in hypertension. Ther Adv Cardiovasc Dis. 2008;2:13–24.
   PubMedGoogle Scholar
• Wang X, Keith JC Jr, Struthers AD, Feuerstein GZ. Assessment of arterial stiffness, a translational medicine biomarker system for evaluation of vascular risk. Cardiovasc Ther. 2008;26:214–23.
   PubMed Web of Science ®Google Scholar
• Lane HA, Smith JC, Davies JS. Noninvasive assessment of preclinical atherosclerosis. Vasc Health Risk Manag. 2006; 2:19–30.
   PubMedGoogle Scholar
• Munzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med. 2008;40:180–96.
   PubMed Web of Science ®Google Scholar
• Rachon D, Teede H. Postmenopausal hormone therapy and the risk of venous thromboembolism. Climacteric. 2008;11:273–9.
   PubMed Web of Science ®Google Scholar
• Mackenzie IS, Wilkinson IB, Cockcroft JR. Assessment of arterial stiffness in clinical practice. QJM. 2002;95:67–74.
   PubMed Web of Science ®Google Scholar
• Wilkinson IB, Hall IR, MacCallum H, Mackenzie IS, McEniery CM, van der Arend BJ, . Pulse-wave analysis: Clinical evaluation of a noninvasive, widely applicable method for assessing endothelial function. Arterioscler Thromb Vasc Biol. 2002;22:147–52.
   PubMed Web of Science ®Google Scholar
• O'Rourke MF, Pauca A, Jiang XJ. Pulse wave analysis. Br J Clin Pharmacol. 2001;51:507–22.
   PubMed Web of Science ®Google Scholar
• Marchais SJ, Guerin AP, Pannier BM, Levy BI, Safar ME, London GM. Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension. 1993; 22:876–83.
   PubMed Web of Science ®Google Scholar
• Wilkinson IB, MacCallum H, Hupperetz PC, van Thoor CJ, Cockcroft JR, Webb DJ. Changes in the derived central pressure waveform and pulse pressure in response to angiotensin II and noradrenaline in man. J Physiol. 2001; 530:541–50.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342:836–43.
   PubMed Web of Science ®Google Scholar
• Davison S, Davis SR. New markers for cardiovascular disease risk in women: Impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab. 2003;88:2470–8.
   PubMed Web of Science ®Google Scholar
• Chan DC, Watts GF. Apolipoproteins as markers and managers of coronary risk. QJM. 2006;99:277–87.
   PubMed Web of Science ®Google Scholar
• Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368–74.
   PubMed Web of Science ®Google Scholar
• Hoikkala H, Haapalahti P, Viitasalo M, Vaananen H, Sovijarvi AR, Ylikorkala O, . Association between vasomotor hot flashes and heart rate variability in recently postmenopausal women. Menopause. 2010;17:315–20.
   PubMed Web of Science ®Google Scholar
• Teede HJ. Sex hormones and the cardiovascular system: Effects on arterial function in women. Clin Exp Pharmacol Physiol. 2007;34:672–6.
   PubMed Web of Science ®Google Scholar
• Mikkola T, Turunen P, Avela K, Orpana A, Viinikka L, Ylikorkala O. 17 Beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab. 1995;80:1832–6.
   PubMed Web of Science ®Google Scholar
• Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas. 2008;60:10–18.
   PubMed Web of Science ®Google Scholar
• Collins P, Mosca L, Geiger MJ, Grady D, Kornitzer M, Amewou-Atisso MG, . Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the raloxifene use for the heart trial: Results of subgroup analyses by age and other factors. Circulation. 2009;119: 922–30.
   PubMed Web of Science ®Google Scholar
• Cano A, Hermenegildo C, Oviedo P, Tarin JJ. Selective estrogen receptor modulators and risk for coronary heart disease. Climacteric. 2007;10:97–111.
   PubMed Web of Science ®Google Scholar
• Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, . Postmenopausal hormone therapy: An endocrine society scientific statement. J Clin Endocrinol Metab. 2010;95:s1–s66.
   PubMed Web of Science ®Google Scholar
• Hemelaar M, van der Mooren MJ, Rad M, Kluft C, Kenemans P. Effects of non-oral postmenopausal hormone therapy on markers of cardiovascular risk: A systematic review. Fertil Steril. 2008;90:642–72.
   PubMed Web of Science ®Google Scholar
• Clarkson TB, Appt SE. MPA and postmenopausal coronary artery atherosclerosis revisited. Steroids. 2003;68:941–51.
   PubMed Web of Science ®Google Scholar
• Beral V; Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362:419–27.
   PubMed Web of Science ®Google Scholar
• Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estradiol-progestogen therapy. Obstet Gynecol. 2009;113:65–73.
   PubMed Web of Science ®Google Scholar
• Allison MA, Manson JE, Aragaki A, Langer RD, Rossouw J, Curb D, . Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause. 2010;17:1136–45.
   PubMed Web of Science ®Google Scholar
• Thurston RC, Kuller LH, Edmundowicz D, Matthews KA. History of hot flashes and aortic calcification among postmenopausal women. Menopause. 2010;17:256–61.
   PubMed Web of Science ®Google Scholar
• Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause. 2009;16:639–43.
   PubMed Web of Science ®Google Scholar
• Svartberg J, von Muhlen D, Kritz-Silverstein D, Barrett-Connor E. Vasomotor symptoms and mortality: The Rancho Bernardo Study. Menopause. 2009;16:888–91.
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133:933–41.
   PubMed Web of Science ®Google Scholar
• Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, . Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: The Women's Health Initiative randomized controlled trial. JAMA. 2004; 291:1701–12.
   PubMed Web of Science ®Google Scholar
• Tuomikoski P. Postmenopausal hot flushes, vascular health and hormone therapy. Academic Dissertation 2010. Helsinki University Faculty of Medicine. Helsinki: Helsinki University Press; 2010.
   Google Scholar